Ikonisys publishes its Full-Year Financial Results for 2022 and provides an update on its latest developments

[ad_1] A year marked by significative strategic investments and by the first sale of the Ikoniscope20 solution, including newly added reagents in partnership with Empire Genomics, to the first US…